Citation Tools
Hepatology
Original research
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance